# EDGAR Filing Document

**Accession Number:** 0001025708
**File Stem:** 0001493152-25-014941
**Filing Date:** 2025-9
**Character Count:** 6285
**Document Hash:** 5fe6d0079d263f9287188f469c6e0dd3
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-25-014941.hdr.sgml**: 20250925

**ACCESSION NUMBER**: 0001493152-25-014941

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D/A

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250925

**DATE AS OF CHANGE**: 20250925

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** RANGE IMPACT, INC.
- **CENTRAL INDEX KEY:** 0001438943
- **STANDARD INDUSTRIAL CLASSIFICATION:** HEAVY CONSTRUCTION OTHER THAN BUILDING CONST - CONTRACTORS [1600]
- **ORGANIZATION NAME:** 05 Real Estate & Construction
- **EIN:** 753268988
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-84210
- **FILM NUMBER:** 251343968

**BUSINESS ADDRESS:**
- **STREET 1:** 200 PARK AVENUE
- **STREET 2:** SUITE 400
- **CITY:** CLEVELAND
- **STATE:** OH
- **ZIP:** 44122
- **BUSINESS PHONE:** 530-231-7800

**MAIL ADDRESS:**
- **STREET 1:** 200 PARK AVENUE
- **STREET 2:** SUITE 400
- **CITY:** CLEVELAND
- **STATE:** OH
- **ZIP:** 44122

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MALACHITE INNOVATIONS, INC.
- **DATE OF NAME CHANGE:** 20211012

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Vitality Biopharma, Inc.
- **DATE OF NAME CHANGE:** 20160721

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Stevia First Corp.
- **DATE OF NAME CHANGE:** 20111020
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** LoConti Joseph E.
- **CENTRAL INDEX KEY:** 0001025708

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A

**MAIL ADDRESS:**
- **STREET 1:** 6140 PARKLAND BLVD.
- **CITY:** MAYFIELD HEIGHTS
- **STATE:** OH
- **ZIP:** 44124

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** LOCONTI JOSEPH E
- **DATE OF NAME CHANGE:** 19961022

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**(Amendment No. 5)**

**RANGE IMPACT, INC.**

*(Name of Issuer)*

**COMMON STOCK**

*(Title of Class of Securities)*

**92849B107**

*(CUSIP Number)*

**Howard Groedel**<br>1660 West 2nd Street,<br>Suite 1100,<br>Cleveland, OH 44113<br>216.583.7000

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**09/23/2025**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **92849B107** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Joseph E. LoConti** | Name of reporting person<br>**Joseph E. LoConti** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**26645789.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**26645789.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**26645789.00** | Aggregate amount beneficially owned by each reporting person<br>**26645789.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**23.73%** | Percent of class represented by amount in Row (11)<br>**23.73%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
COMMON STOCK

**(b) Name of Issuer:**
RANGE IMPACT, INC.

**(c) Address of Issuer's Principal Executive Offices:**
200 PARK AVENUE, SUITE 4, CLEVELAND, OH, 44122

This Amendment No. 5 ("Fifth Amendment") amends the Reporting Person's initial Schedule 13D filed on November 1, 2018, as amended on February 7, 2019, April 2, 2019, May 27, 2022 and January 23, 2025 (as amended, the "Schedule 13D") with respect to the shares of the Common Stock, par value $0.001 per share ("Common Stock"), of Range Impact, Inc. (the "Company"). Capitalized terms used but not otherwise defined in this Fifth Amendment have the meanings ascribed to such terms in the Schedule 13D. The purpose of this Fifth Amendment is to report a change in the number of shares of the Common Stock of the Company beneficially owned by the Reporting Person.

**Item 5. Interest in Securities of the Issuer**

**(a)**
Mr. LoConti has the sole power to vote and dispose of 26,645,789 shares of the Common Stock of the Company representing approximately 23.73% of the total number of shares of Common Stock of the Company outstanding as of the date of this Fifth Amendment.

**(b)**
Not applicable.

**(c)**
Tower IV acquired 2,333,333 shares of Common Stock of the Company in a privately-negotiated transaction pursuant to a Securities Purchase Agreement entered into between Tower IV and the Company, dated September 23, 2025. The consideration paid by Tower IV for the shares of Common Stock acquired pursuant to the Securities Purchase Agreement was $550,000 or $0.15 per share of Common Stock acquired.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Joseph E. LoConti

**Signature:** /s/ Joseph E. LoConti

**Name/Title:** Joseph E. LoConti

**Date:** 09/25/2025